organoid based drug screening (Selleck Chemicals)
Structured Review
Organoid Based Drug Screening, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 94/100, based on 63 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/compound/Epigenetics+Compound+Library/pmc13683295-285-4-13
Average 94 stars, based on 63 article reviews
Images
Related Articles
Drug discovery:Article Title: Integrative multi-omics combined with functional pharmacological profiling in patient-derived organoids identifies personalized therapeutic vulnerabilities of adult high-grade gliomas Article Snippet: PDOs were maintained at 37°C with 5% CO 2 and atmospheric oxygen in DMEM medium supplemented with 10% FBS, 2 mM L-glutamine, 0.4 mM NEAA, and 100 U/mL penicillin-streptomycin (all from Lonza). .. Drug screening included epigenetic compound library from SelleckChem ( Article Title: Epigenetic buffering of proteotoxic stress by EHMT2 enables meningioma growth Article Snippet: .. The CH-157MN established human meningioma cell line was plated at a density of approximately 2000 cells/well in 384-well culture dishes for 24 h. The cells were then exposed in triplicate for 48 h to compounds obtained from the Library of Pharmacologically Active Compounds (LO1280, Sigma) at a concentration of 10 μM, a kinase inhibitor library (L1200, SelleckChem) at a concentration of 2 μM, or an Article Title: Pre-Clinical Combination Targeting VEGF and PI3K in a Rare, Aggressive Mixed Endometrial Carcinoma: An Applied Case Report Article Snippet: .. We utilized several drug 209 libraries including ApexBio FDA-Approved Drug Library, ( Article Title: Curcumin analogue FLLL32 induces ferroptosis by targeting the STAT3-GPX4/SLC40A1 axis in colorectal cancer Article Snippet: Ferrostatin-1 (MedChemExpress, HY-100579) and Z-VAD-FMK (MedChemExpress, HY-16658B) were dissolved in DMSO. .. The compounds used for Article Title: ARID1A deficiency activates OSM-STAT3 axis in endometrial cancer, creating vulnerability to JAK/STAT3 inhibition Article Snippet: .. Concentration Assay:Article Title: Epigenetic buffering of proteotoxic stress by EHMT2 enables meningioma growth Article Snippet: .. The CH-157MN established human meningioma cell line was plated at a density of approximately 2000 cells/well in 384-well culture dishes for 24 h. The cells were then exposed in triplicate for 48 h to compounds obtained from the Library of Pharmacologically Active Compounds (LO1280, Sigma) at a concentration of 10 μM, a kinase inhibitor library (L1200, SelleckChem) at a concentration of 2 μM, or an Library Screening:Article Title: DNA methyltransferase inhibition is a therapeutic vulnerability in VHL-deficient renal cell carcinoma cells. Article Snippet: .. Article Title: ARID1A deficiency activates OSM-STAT3 axis in endometrial cancer, creating vulnerability to JAK/STAT3 inhibition Article Snippet: .. |
![Reaction schemes and LC-MS analysis of Pp UGTs reactions with diosgenin and pennogenin . ( a ) Biosynthesis of <t>trillin</t> mediated by UGT91BP2 and UGT703R1–3 through transferring glucose from UDP-glucose to the C-3 OH position of diosgenin. ( b ) Extracted ion chromatograms (EICs) of the in vitro enzyme activity assays of recombinant UGT91BP2 and UGT703R1–3 with UDP-glucose and diosgenin showing the formation of trillin, as compared to the authentic trillin standard. Control is the empty expression vector. ( c ) MS spectra of the enzymatic reaction products in hydrogen and sodium ion adducts compared to the fragmentation pattern of the trillin standard. The product molecular ions [M + H] + and [M +Na] + and the feature fragment ion [M + H − Glc] + with m / z 415.32 are marked. Of note, additional peaks observed in the diosgenin EIC ( m / z 415.32) for UGT703R1–3 might correspond to substrate isomeric impurities, in-source adducts, or minor non-enzymatic by-products; these peaks, which arose from the extracted ion flow of the substrate m / z , did not co-elute with the product, trillin , and therefore did not affect the interpretation of the product formation. ( d ) Biosynthesis of pennogenin 3- O -glucoside mediated by the UGT703R1–3 through transferring glucose from UDP-glucose to the C-3 OH position of pennogenin. ( e ) EICs of the in vitro enzyme activity assays of recombinant UGT91BP2 and UGT703R1–3 with UDP-glucose and pennogenin showing the formation of pennogenin 3- O -glucoside, compared to the control empty expression vector. ( f ) MS/MS spectra ([M + H – Glc] + and [M + H – Glc − H 2 O] + ) of the enzymatic reaction products.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_3502/pmc13123502/pmc13123502__gr2.jpg)
